Delivery Order SPE2DB22D2206-SPE2DB25FJX45
- Not listed
- This is a $1,565.09 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Azelastine HCL 0.05% eye drops, a medication used to treat eye allergies. The order has a completion date of July 1, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which...
- The Defense Logistics Agency awarded a $1,002.16 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Azelastine 0.1% (137 mcg) spray in a 30ml formulation. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 26, 2025. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,523.57, is for the delivery of Azelastine 0.1% eye drops. The contract is a Firm Fixed Price Delivery Order with a completion date of June 26, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $119.60 to Amerisourcebergen Drug Corporation for 4561435749 AZELASTINE HCL 0.05% drops, 6mL. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 10, 2023 to support Defense Logistics Agency requirements. The parent company, Amerisourcebergen Corporation, will perform through its Amerisourcebergen division. No...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,751,027 units of the drug Azelastine HCL 0.05% Drops in 6 mL bottles. The fixed-price delivery order, valued at $3,475.53, has an ultimate completion date of April 1, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) through...
- Defense Logistics Agency awarded a $266 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4562143245 AZELASTINE HCL 0.05% DROPS 6ML. As the parent company, Amerisourcebergen Corporation will perform the order through its Corporate Office location in Conshohocken, Pennsylvania by the required completion date of September 13, 2023. No set-aside designation was applied. This order is likely associated with DLA's medical supply program to support the U.S. military and will deliver...
- This is a $3,376.01 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Azelastine 0.1% (137 MCG) spray, a prescription medication, with a completion date of March 6, 2024. This delivery order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $358.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561653247 AZELASTINE HCL 0.05% DROPS 6ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill requirements under the contract ending August 1, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency functions to...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $358.80 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 4562122553 AZELASTINE HCL 0.05% DROPS 6ML to be delivered to a location in Conshohocken, Pennsylvania. The period of performance for this order is September 11-12, 2023. No major subcontractors or set aside designations were indicated. This order was issued under an existing DLA medical supply vehicle to...
- The Defense Logistics Agency awarded a $168,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561976215 AZELASTINE HCL 0.05% DROPS 6ML. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania under a one-day period of performance starting and ending on August 29-30, 2023. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJX45Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Azelastine HCL 0.05% ophthalmic drops in 6ml units, valued at $2,620.74. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement that supports the military's global pharmaceutical supply chain through December 2026. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. As a major pharmaceutical distributor specializing in federal medical procurement, AmerisourceBergen Drug Corp serves critical healthcare needs across military and veteran systems through the DLA. The company's extensive federal contract portfolio demonstrates proficiency in delivering diverse pharmaceutical products, from generic medications to specialty pharmaceuticals, across multiple therapeutic domains. This particular delivery order for Azelastine—a topical antihistamine commonly used for allergic conjunctivitis—exemplifies the routine pharmaceutical supply operations that support Department of Defense healthcare operations worldwide through the company's comprehensive prime vendor vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/12/25 |